Pharmaco-therapeutic cycloferon efficacy in pediatric practice
The article presents the authors and literary data on cycloferon pharmacotherapeutic eﬃciency - the drug belonging to the group of interferon inductors, immunomodulators. Cycloferon eﬀect in treatment of diﬀer- ent socially important children diseases, including acute respiratory viral infections, bronchial asthma, aller- gic states, accompanied by the disorders of anti-infectious protection, mycoplasmic infection, broncho-pul- monary complications in acute respiratory viral infections with the low degree of radical oxidation intensity is described. Autoimmune process suppression, which is the cause of postvaccinal complications in often ill children, by cycloferon on the background of planned vaccination is shown. Results of cycloferon use in treat- ment of gastrointestinal tract disorders, intestinal infections both of viral and bacterial genesis are presented. Cycloferon is suggested for intestinal disbiosis correction. In 95% of children microﬂora restoration to the normal level was noted. The drug use for surgical pathology, particularly for appendicular peritonitis, with the aim to decrease postoperative complications and also for the correction of immune disorders in children with chronic viral hepatitis A and B, treated by complex therapy, is described. Cycloferon safety and eﬃciency is conﬁrmed by the postmarketing randomized studies.